Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	Participants With Accelerated Phase CML
Total, all-cause mortality	Participants With Chronic Myelogenous Leukemia(CML);QD Dosing
Total, all-cause mortality	Participants With CML; BID Dosing
Total, all-cause mortality	Participants With Myeloid Blast Phase CML
Total, other adverse events	Participants With Accelerated Phase CML	5	5
Total, other adverse events	Participants With Chronic Myelogenous Leukemia(CML);QD Dosing	21	22
Total, other adverse events	Participants With CML; BID Dosing	15	15
Total, other adverse events	Participants With Myeloid Blast Phase CML	4	4
Total, serious adverse events	Participants With Accelerated Phase CML	3	5
Total, serious adverse events	Participants With Chronic Myelogenous Leukemia(CML);QD Dosing	10	22
Total, serious adverse events	Participants With CML; BID Dosing	9	15
Total, serious adverse events	Participants With Myeloid Blast Phase CML	3	4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00978731/event-totals